Advertisement
News
Advertisement

Synageva finds $25M financing for enzyme treatment

Mon, 03/21/2011 - 6:38am
Mass High Tech: The Journal of New England Technology

Synageva BioPharma Corp. has landed a $25 million private equity funding to support development of the Lexington biotech’s enzyme replacement therapy, SBC-102.

The $25 million brings the company’s funding up to $70 million in the last two and a half years.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading